With Senate Returning to Washington in Search of Affordability Solutions, Shaheen Pushes for Floor Vote on Bipartisan Bill to Cap Monthly Insulin Costs

(Washington, DC) – With the U.S. Senate returning to Washington in search of solutions that address the nation’s overwhelming affordability concerns , U.S. Senator Jeanne Shaheen (D-NH) is calling for a floor vote on her bipartisan, bicameral legislation to cap monthly insulin costs. The INSULIN Act would cap monthly out-of-pocket insulin costs at $35 and continues to gain momentum in the House and Senate. As Senate leaders seek cost-of-living solutions for the American people , Senators on both sides of the aisle are increasingly pointing to the INSULIN Act as an immediate, broadly supported step Congress can take to lower health care costs. Over 40 million Americans live with diabetes, and Shaheen’s INSULIN Act would make a direct impact by lowering the cost of life-saving insulin for millions across the country. “President Trump campaigned on immediately lowering costs for the American people, yet he’s done just the opposite. With millions of American families facing spiking prices as a result of this Administration’s disastrous health care policies, my INSULIN Act is one immediate step Congress can take to directly lower costs for millions of Americans. That’s why it has dozens of bipartisan cosponsors across the House and Senate, and why momentum is growing to take action on the bill,” said Senator Shaheen . “I’ve fought to pass this legislation for years and we are closer than ever before to achieving that goal. I’m joining calls to bring this bill to the floor and show the American people that Congress can still achieve meaningful, bipartisan progress to make life more affordable.” Throughout the August recess and into September, momentum has grown for the INSULIN Act . Recent reporting by Punchbowl News and the New Hampshire Bulletin highlight how Shaheen continues to hear from her constituents and advocate for the passage of her legislation to address affordability concerns. And just last week, reporting from The Washington Sun laid out the “groundswell” of support for the INSULIN Act from Senate Republicans across the ideological spectrum who believe it would make a real impact to bring down costs for the American people. The current push for the INSULIN Act comes after the legislation was recently introduced in the House and advanced out of the Senate Health, Education, Labor and Pensions (HELP) Committee on a strong bipartisan basis—two major steps for the legislation. Senator Shaheen has led efforts to lower health care costs for Granite Staters and Americans. As co-chair of the U.S. Senate Diabetes Caucus, Senator Shaheen has consistently pressed to hold insulin manufacturers, insurers and pharmacy benefit managers accountable for the skyrocketing cost of life-saving insulin and otherwise support patients and families facing diabetes. Polling released from the American Diabetes Association this summer found that 40% of respondents who rely on insulin report paying more than $150 per month for insulin, and 76% of respondents across political parties support a $35 limit on cost sharing for insulin. ###